Dear Mr. Berko: Several times in the past couple of months, you’ve said the Dow Jones industrial average will reach 30,000 in the coming 10 years. You must be smoking
Accelerate in Which Direction?
Dear Mr. Berko: I think it was in August that you wrote a short comment about Accelerate Diagnostics. At the time, it was trading at $19. I’ve been a nurse
5 Small-Cap Biotech Stocks to Buy in February
Celldex, Geron, Halozyme, Lexicon, and Synergy look like good small-cap biotech stocks for investors not afraid to take on risk. Looking to add a few thrills to your investing portfolio?
4 Dividend Stocks That’ll Likely Raise Their Payouts for a 55th Consecutive Year
These household brands, and one under-the-radar company, are the hallmarks of dividend consistency. Dividends stocks are the heart and soul of most retirement portfolios. Historically, dividend stocks have handily outperformed
The Dow Breaks 20,000: What Happens Next?
Is it just a number, or does cracking through a milestone mean something for the market? The Dow Jones Industrial Average(DJINDICES:$INDU) is over 20,000! The media is lauding this feat, but should investors
Death star for Enterprise Florida and Visit Florida?
There’s a big feud between Gov. Rick Scott and the Florida Legislature with Enterprise Florida and Visit Florida right in the crosshairs. A bill in the Florida House would kill
JetBlue Airways Is My Top Stock Pick for 2017: Here’s Why
With unit revenue comparisons about to get a lot easier and plenty of profit growth initiatives in the works, JetBlue could be a great stock to own in 2017. After
SoBe Flavor
Yachts Miami Beach plans a high-end show By Martin Lenkowsky Yachts Miami Beach aims to attract an exclusive crowd this year by featuring a new VIP experience on the Grand
The Health of PETS
Dear Mr. Berko: I’m a 65-year-old single woman, and using your column, I’ve picked some good stocks that have nicely grown. The value of my individual retirement account is now
Actelion and Kraig Biocraft
Dear Mr. Berko: What do you think of Actelion Pharmaceuticals? I bought 400 shares at $42 last June, and they’re now worth $56 each. Would you consider this a short-term